Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Bipolar Disorder Clinical Trials

100 recruiting trials for Bipolar Disorder. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
5
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05669703

NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder

Background: Mood disorders, such as bipolar disorder, can have serious effects on a person s life. People with bipolar disorder are more likely to have heart disease and abuse...

Sponsor: National Institute of Mental Health (NIMH)Enrolling: 12601 location
RECRUITINGNCT04296604

Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric...

Sponsor: Massachusetts General HospitalEnrolling: 6001 location
RECRUITINGPhase 4NCT04828226

Clonidine to Prevent Delirium After Electroconvulsive Therapy.

Electroconvulsive therapy (ECT) is a highly effective treatment for some psychiatric disorders like major depressive or bipolar disorder, but may lead to agitation and delirium...

Sponsor: Insel Gruppe AG, University Hospital BernEnrolling: 1301 location
RECRUITINGPhase 2NCT05786066

The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

The purpose of this study is to test the hypothesis that the anti-depressant and anti-suicidal effects of the N-methyl-D-aspartate receptor (NMDAR) antagonist Ketamine is...

Sponsor: Yale UniversityEnrolling: 301 location
RECRUITINGNCT06657430

A Study on the Preference of Risperidone Dosage Forms

This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.

Sponsor: Shanghai Mental Health CenterEnrolling: 10001 location
RECRUITINGNCT06616116

Stress Management with Real-time Bio-signal Biofeedback

The goal of this clinical trial is to learn if the real-time bio-signal monitoring device (Neuronicle FX2 device), combined with mindfulness-based cognitive therapy (MBCT), helps...

Sponsor: Seoul National University HospitalEnrolling: 1001 location
RECRUITINGPhase 4NCT05913947

Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)

The goal is to study the effect of lithium compared to cariprazine in patients with depression in a bipolar disease. The main question it aims to answer is: Difference in change...

Sponsor: Aalborg University HospitalEnrolling: 1221 location
RECRUITINGNCT06729541

Development and Application of Precision Treatment Strategies for Common Mental Disorders

Schizophrenia (SCH), major depressive disorder (MDD), and bipolar disorder (BPD) are prevalent, disabling psychiatric conditions that not only cause significant suffering for...

Sponsor: Peking UniversityEnrolling: 6001 location
RECRUITINGNCT04815239

Early Intervention for Youth at High Risk for Bipolar Disorder

Investigators will conduct a confirmatory efficacy trial of Interpersonal and Social Rhythm Therapy (IPSRT) delivered via telehealth for offspring of bipolar parents (OBP; age...

Sponsor: University of PittsburghEnrolling: 1201 location
RECRUITINGPhase 4NCT04580134

CLOZAPINE Response in Biotype-1

The CLOZAPINE study is designed as a multisite study across 5 sites and is a clinical trial, involving human participants who are prospectively assigned to an intervention. The...

Sponsor: University of Texas Southwestern Medical CenterEnrolling: 5245 locations
RECRUITINGNCT04230421

Effects of Smartphone-based Treatment for Bipolar Disorder - the Smart Bipolar

The Smart Bipolar RCT is a pragmatic RCT aiming to investigate effects of smartphone-based add on treatment in large scale clinical practice (N= 200 patients).

Sponsor: Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg HospitalEnrolling: 2001 location
RECRUITINGNCT05178966

Evaluation of Efficiency of One Day Patient/Caregiver Psychoeducation on the Caregiver's Burden

Bipolar disorder (BD) has a huge impact on the lives of patient and their relatives. Psychoeducation programs on BD has been shown to be effective on the burden of patients and...

Sponsor: University Hospital, MontpellierEnrolling: 2401 location
RECRUITINGPhase 2NCT06922318

The COSMYC Trial (COmbined Suppression of MYC)

This research is being done to determine if receiving the combination of testosterone and ZEN-3694 followed by the combination of enzalutamide plus ZEN-3694 will decrease the size...

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsEnrolling: 501 location
RECRUITINGNCT07306468

Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life

This observational study aims to evaluate exercise capacity, pulmonary function, respiratory muscle strength, and quality of life in individuals diagnosed with schizophrenia and...

Sponsor: Çankırı Karatekin UniversityEnrolling: 1501 location
RECRUITINGNCT06393907

Hemostatic Forceps vs. Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers

A randomized controlled trial to evaluate the efficacy of hemostatic forceps and bipolar electrocautery probes in patient with high risk bleeding gastroduodenal ulcers.

Sponsor: Mahidol UniversityEnrolling: 1501 location
RECRUITINGNCT07247344

Multimodal Phenotyping in Adolescent Inpatient Depression: An Observational Study

This cohort study involves the dynamic collection of clinical information from adolescent patients with major depressive episodes (including both major depressive disorder and...

Sponsor: Jiangsu Province Nanjing Brain HospitalEnrolling: 10001 location
RECRUITINGPhase 2NCT07046494

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder

This is a clinical research study for an investigational drug called RAP-219 in participants with bipolar I disorder. This study is being conducted to determine if RAP-219 is safe...

Sponsor: Rapport Therapeutics Inc.Enrolling: 22420 locations
RECRUITINGNCT00201526

Bipolar Research And Innovation Network - BRAIN

To describe the broad spectrum of Bipolar Disorder patients admitted to out-patient and in-patient psychiatric departments in Norway. Include all admitted Bipolar patients both...

Sponsor: Norwegian University of Science and TechnologyEnrolling: 30001 location
RECRUITINGNCT06134349

The Bipolar Lithium Imaging Scan Study.

The main goal of this study is to determine if brain lithium-concentrations predict clinical lithium treatment-response. Secondary, to study correlations between intracerebral...

Sponsor: Leiden University Medical CenterEnrolling: 801 location
RECRUITINGNCT05627492

Pragmatic Patient-oriented Extension Study of Dialectical Behavior Therapy Booster Sessions for Youth With and/or at...

The study intervention is DBT adapted for youth with and/or at familial risk for bipolar disorder. Participants will have completed one full year of DBT in a previous study. This...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 1201 location
RECRUITINGNCT07213492

Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder

People with bipolar disorder (BD) are at high risk of relapse following hospital discharge, partly due to a lack of BD-specific expertise and resources within community services...

Sponsor: McMaster UniversityEnrolling: 101 location
RECRUITINGNCT06462196

Natural History of Depression, Bipolar Disorder and Suicide Risk

Mood disorders, such as depression and bipolar disorder, are difficult to treat. One reason is that there are no objective ways to measure how these disorders affect the body and...

Sponsor: National Institute of Mental Health (NIMH)Enrolling: 5001 location
RECRUITINGPhase 2NCT07288320

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current...

The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving manic symptoms in adults with bipolar I disorder who are...

Sponsor: Neurocrine BiosciencesEnrolling: 1506 locations
RECRUITINGNCT04806620

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from...

Sponsor: Brain Inflammation CollaborativeEnrolling: 100001 location
RECRUITINGNCT05384405

aiTBS for Relieving NSSI in Depressive Patients

Repetitive transcranial magnetic stimulation (rTMS) has been successfully used to help patients with treatment resistant depression. However, its role in alleviating self injuries...

Sponsor: Central South UniversityEnrolling: 601 location
RECRUITINGPhase 4NCT07047651

Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.

The effectiveness and efficacy of the combination of pharmacotherapy with the two new recovery-oriented programs, RECOVERYTRSGR for patients with treatment- resistant...

Sponsor: Dr. Stavroula RakitziEnrolling: 401 location
RECRUITINGNCT07221864

Decoding Emotional Dynamics in Bipolar Disorder

The goal of this neuroimaging study is to investigate how emotional states fluctuate in people with bipolar disorder (BD) compared to healthy controls, and to understand the...

Sponsor: Laureate Institute for Brain Research, Inc.Enrolling: 721 location
RECRUITINGNCT05767073

LIVES: Personalized Lifestyle Intervention for Patients With Depression

Persons with affective disorder have a considerably increased risk of cardiovascular disease. To a considerable extent, this is due to an unhealthy life style. At present, no...

Sponsor: University Medical Center GroningenEnrolling: 382 locations
RECRUITINGEarly Phase 1NCT06482762

Low-Intensity Focused Ultrasound of the Amygdala for Bipolar Disorder

The specific aim of this proposed study is to investigate the feasibility and therapeutic potential of transcranial focused ultrasound (tFUS) as a treatment for bipolar disorder...

Sponsor: Massachusetts General HospitalEnrolling: 201 location
RECRUITINGNCT06672562

Narrative Enhancement and Cognitive Therapy for Self-Stigma in Youth

The goal of this pilot clinical trial is to assess the feasibility of conducting a full-scale study to learn if a new youth-adapted Narrative Enhancement and Cognitive Therapy...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 961 location
RECRUITINGNCT04432116

Time and Virtual Reality in Schizophrenia and Bipolar Disorder

Patients with bipolar disorders report an acceleration or slowing of time flow, and patients with schizophrenic spectrum disorders a time fragmentation. These disorders would be...

Sponsor: Institut National de la Santé Et de la Recherche Médicale, FranceEnrolling: 1201 location
RECRUITINGNCT05802446

Neurofeedback for Bipolar Disorder

Bipolar Disorder (BD) is a severe mood disorder affecting between 1% and 3% of the general population. It is characterized by the succession of depressive and manic episodes, with...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 641 location
RECRUITINGNCT05153369

Three-level Model of DBT-informed Care for Youth With and/or at Familial Risk for Bipolar Disorder (DB3)

This study seeks to bridge the knowledge-to-action gap regarding psychosocial treatment "dosing" for youth with and/or at familial risk for bipolar disorder (BD). In psychiatry,...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 601 location
RECRUITINGNCT07402954

Stimulation of External Carotid Artery Circulation

This study is testing a new approach to help people with migraine headaches. Researchers want to find out if using electrical stimulation to affect blood flow in the external...

Sponsor: The University of Texas Medical Branch, GalvestonEnrolling: 121 location
RECRUITINGNCT05427123

Children's Bipolar Network Treatment Trial I

This is a naturalistic treatment and follow-up study of youth with bipolar spectrum disorders (BSDs) across four US sites of The Childhood Bipolar Network (CBN). CBN sites have...

Sponsor: University of California, Los AngelesEnrolling: 804 locations
RECRUITINGPhase 2NCT05064319

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

This research study evaluates the effects of an FDA-approved medication Gabapentin in individuals with Bipolar Disorder who smoke marijuana. Participants in the study will will be...

Sponsor: Medical University of South CarolinaEnrolling: 681 location
RECRUITINGPhase 4NCT06184581

Lithium Versus Lamotrigine in Bipolar Disorder, Type II

The investigators want in a 6-month randomized controlled trial (RCT) to compare effects of lithium versus lamotrigine on mood stabilization and other critical patient outcomes in...

Sponsor: University Hospital Bispebjerg and FrederiksbergEnrolling: 2001 location
RECRUITINGNCT05384392

Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode

Psychosis is a severe, common, and disabling psychological disorder. An epidemiological study conducted in England reported an incidence of 34 new cases per 100,000 person-years,...

Sponsor: University Hospital, BrestEnrolling: 2176 locations
RECRUITINGPhase 2NCT05296356

OSU6162 in Bipolar Depression (OBID)

An explorative, open label, single armed, flexible dose, single center, phase IIa study of 8 weeks, initiated in subjects with bipolar depression. The study will consist of 9...

Sponsor: Göteborg UniversityEnrolling: 221 location
RECRUITINGNCT06649357

Comparison Between Bipolar Transurethral Resection of the Prostate and Moses Assisted Holmium Laser Enucleation of the...

Introduction: Multiple studies have demonstrated the superiority of HoLEP in aspects such as transfusión rates or postoperative stay. On the other hand, no differences have been...

Sponsor: Fundacio PuigvertEnrolling: 1306 locations
RECRUITINGNCT07406945

Safety and Efficacy of a Novel SpydrBlade Flexible Bipolar in POEM

Achalasia is an idiopathic motility disorder, primarily identified by the absence of esophageal peristalsis and the inability of the lower esophageal sphincter (LES) to relax...

Sponsor: Chinese University of Hong KongEnrolling: 732 locations
RECRUITINGNCT06804525

LHC-CIDI-5 in Hong Kong

The World Health Organization Composite International Diagnostic Interview-5th (CIDI-5) is a standardized diagnostic tool used to assess the prevalence of mental and substance use...

Sponsor: The University of Hong KongEnrolling: 25001 location
RECRUITINGNCT07167563

Real-world Lithium Intake

The aim of the present study is to study compliance with lithium therapy and patterns of lithium intake among a representative group of patients with bipolar disorder in a...

Sponsor: University of AarhusEnrolling: 501 location
RECRUITINGNCT06384755

Honest Open Proud for Psychotic and Bipolar Disorder in Norway

The purpose of this pilot study is to evaluate the feasibility, acceptability and efficacy of a Norwegian adaptation of the group-based intervention 'Honest Open Proud' among...

Sponsor: Oslo University HospitalEnrolling: 402 locations
RECRUITINGNCT06476678

Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions

Both Baylor St Luke's Medical Center and Mayo Scottsdale are considered endoscopic submucosal dissection (ESD) centers of excellence. The investigators at Baylor College of...

Sponsor: Baylor College of MedicineEnrolling: 501 location
RECRUITINGNCT06182787

Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient

This study presents the development and validation of a unique Digital Experience Sampling Method (ESM) questionnaire specifically adapted for monitoring changes in the mental...

Sponsor: Sheba Medical CenterEnrolling: 1301 location
RECRUITINGPhase 2NCT06594926

Working Out M0 Bipolar Androgen Therapy

The WOMBAT study will test if BAT can prolong the time it takes for nmCRPC prostate cancer to become detectable in other areas of the body (metastatic disease). Approximately 69...

Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials GroupEnrolling: 6912 locations
RECRUITINGNCT07398365

Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients

This observational study will characterise the general psychiatric and general medical phenotypes of 100 adults, sequentially admitted to NHS General Adult Psychiatry (GAP)...

Sponsor: University of EdinburghEnrolling: 1001 location
RECRUITINGNCT06274567

Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder

The objective of this study protocol is to test whether intermittent theta-burst transcranial magnetic stimulation (iTBS-TMS) to the inferior parietal lobule (IPL) can strengthen...

Sponsor: Massachusetts General HospitalEnrolling: 1362 locations
RECRUITINGNCT06408012

An Innovative Master Platform for Clinical Trials in Mood Disorders

Mood disorders such as depression and bipolar disorder affect over 350 million people around the world. While several effective treatments exist, it is often difficult to match...

Sponsor: St. Joseph's Healthcare HamiltonEnrolling: 9009 locations

Showing 50 of 100 trials.Search all Bipolar Disorder trials

Frequently Asked Questions

There are currently 100 clinical trials for Bipolar Disorder, with 100 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Bipolar Disorder, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 5 Phase 3 trials for Bipolar Disorder, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.